Synthesis and evaluation of the acetylcholinesterase inhibitory effect of novel heteroaromatic derivatives bearing a 2-(5-(pyridin-2-yl)-1H-tetrazol-1-yl)acetamide scaffold

Acetylcholinesterase (AChE) has been one of the important and potential targets in the discovery, and development of new drugs for treating and slowing the progression of Alzheimer's disease (AD). This research suggests potential structural frameworks for synthesizing AChE inhibitor derivatives for treating AD.